Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates
- PMID: 30668155
- PMCID: PMC6759325
- DOI: 10.1080/21678421.2018.1556695
Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates
Abstract
Objective: Behavioral variant frontotemporal dementia (bvFTD), is commonly considered the cognitive presentation of the frontotemporal dementia-motor neuron disease (FTD-MND) spectrum disorder. We evaluated the prevalence of primary progressive aphasia in a series of pathologically confirmed cases of FTD-MND spectrum. Methods: Pathologically confirmed cases of frontotemporal lobar degeneration-motor neuron disease (FTLD-MND) were obtained from the UCSF brain bank. Cases were analyzed for presence of language impairment via retrospective chart review of research visits that include neurologic exam, in-depth cognitive testing and magnetic resonance imaging (MRI) imaging. Forty one cases were included. Thirty two were diagnosed with FTD-MND, while nine cases were diagnosed as MND-only from clinical evaluation. Results: Ten FTLD-MND cases (31%) presented with prominent or isolated language involvement consistent with a diagnosis of primary progressive aphasia (PPA), which we called progressive aphasia with motor neuron disease (PA-MND). Of these, three cases that mirrored the non-fluent variant of PPA (nfvPPA) were named nfvPA-MND. The imaging pattern of these nfvPA-MND showed atrophy strictly confined to the frontal and anterior temporal language cortical areas. Another group of seven cases that resembled patients with the semantic variant PPA (svPPA) were named svPA-MND. The group of svPPA-MND on imaging analysis showed selective atrophy of the temporal lobe and orbitofrontal cortex. Conclusions: Language impairment was a frequent phenotype of FTD-MND associated with focal atrophy patterns within the language networks. This data suggest patients with FTD-MND can present quite often with language phenotype of nfvPPA and svPPA, as opposed to exclusive bvFTD symptoms.
Keywords: Neuropathology; amyotrophic lateral sclerosis; dementia; frontotemporal dementia; imaging; motor neuron disease; primary progressive aphasia.
Figures
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3512/6759325/05bab3ad3019/nihms-1016881-f0001.gif)
![Figure 2.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3512/6759325/69a210df418a/nihms-1016881-f0002.gif)
![Figure 3.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3512/6759325/86df9789616e/nihms-1016881-f0003.gif)
![Figure 4.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3512/6759325/03fbba113685/nihms-1016881-f0004.gif)
Similar articles
-
Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.J Neurol. 2019 Apr;266(4):921-933. doi: 10.1007/s00415-019-09216-0. Epub 2019 Feb 1. J Neurol. 2019. PMID: 30707358
-
Transdiagnostic Network Localization of Social, Language, and Motor Symptoms in Patients With Frontotemporal Lobar Degeneration.Neurology. 2024 Dec 24;103(12):e210108. doi: 10.1212/WNL.0000000000210108. Epub 2024 Nov 25. Neurology. 2024. PMID: 39586043
-
Atrophy network mapping of clinical subtypes and main symptoms in frontotemporal dementia.Brain. 2024 Sep 3;147(9):3048-3058. doi: 10.1093/brain/awae067. Brain. 2024. PMID: 38426222 Free PMC article.
-
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. CNS Drugs. 2012. PMID: 22950490 Review.
-
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration.Semin Nucl Med. 2021 May;51(3):264-274. doi: 10.1053/j.semnuclmed.2020.12.002. Epub 2021 Jan 2. Semin Nucl Med. 2021. PMID: 33402272 Review.
Cited by
-
Human Endogenous Retroviruses in Neurodegenerative Diseases.Genes (Basel). 2024 Jun 5;15(6):745. doi: 10.3390/genes15060745. Genes (Basel). 2024. PMID: 38927681 Free PMC article. Review.
-
Non-fluent Primary Progressive Aphasia and Its Association to Motor Neuron Disease.Cureus. 2024 Aug 8;16(8):e66447. doi: 10.7759/cureus.66447. eCollection 2024 Aug. Cureus. 2024. PMID: 39246926 Free PMC article.
-
Speech and Language Presentations of FTLD-TDP Type B Neuropathology.J Neuropathol Exp Neurol. 2020 Mar 1;79(3):277-283. doi: 10.1093/jnen/nlz132. J Neuropathol Exp Neurol. 2020. PMID: 31995205 Free PMC article.
-
Primary Progressive Aphasia: Toward a Pathophysiological Synthesis.Curr Neurol Neurosci Rep. 2021 Feb 4;21(3):7. doi: 10.1007/s11910-021-01097-z. Curr Neurol Neurosci Rep. 2021. PMID: 33543347 Free PMC article. Review.
-
[Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum].Rev Neurol. 2022 Jan 16;74(2):37-47. doi: 10.33588/rn.7402.2021197. Rev Neurol. 2022. PMID: 35014018 Free PMC article. Spanish.
References
-
- Neary D, Snowden J. Frontal lobe dementia, motor neuron disease, and clinical and neuropathological criteria. J Neurol Neurosurg Psychiatry. 2013;84:713–4. - PubMed
-
- Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother. 2015;15:509–22. - PubMed
-
- Burrell JR, Halliday GM, Kril JJ, Ittner LM, Gotz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919–31. - PubMed
-
- Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain J Neurol. 2011;134:2582–94. - PubMed
Publication types
MeSH terms
Grants and funding
- P50 AG023501/AG/NIA NIH HHS/United States
- K24 AG045333/AG/NIA NIH HHS/United States
- U01 AG052943/AG/NIA NIH HHS/United States
- K23 AG048291/AG/NIA NIH HHS/United States
- P01 AG019724/AG/NIA NIH HHS/United States
- R01 NS100440/NS/NINDS NIH HHS/United States
- K08 AG052648/AG/NIA NIH HHS/United States
- K24 DC015544/DC/NIDCD NIH HHS/United States
- T32 AG023481/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- R56 NS050915/NS/NINDS NIH HHS/United States
- R01 NS050915/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources